DEF Biologic & Small Molecule NP/PA CME Virtual Bootcamp March 2021
The live program has concluded.
If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.
Details
Overview
NoneSupported by an unrestricted educational grant from Leo Pharma Learning Objectives
- Describe recent advances in biologic drug development, regulations, and indications in immune-mediated inflammatory diseases (IMIDs), with emphasis on psoriasis, PsA and AD.
- Critically appraise and discuss relevant evidence on pathophysiology and immunology as applied to psoriasis, psoriatic arthritis and atopic dermatitis.
- Develop strategies to predict, prevent, and treat potential side effects and complications encountered with biologic agents.
- Review data regarding associated comorbid conditions associated with psoriasis, PsA, and AD including but not limited to cardiovascular disease, diabetes, obesity, and depression.
- Analyze recent investigations on safety, efficacy, and toxicity of biologic agents across IMIDs.
- Through case-based presentation and discussion panels, summarize updates in diagnosis, classification, therapies, and immune-system targets in psoriasis, PsA, and AD and describe their clinical implications.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
4.00 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!